Soluble Interleukin-2 Receptor, Soluble CD8 and Soluble Intercellular Adhesion Molecule-1 Levels in Hematologic Malignancies

References

• Altman A., Mustelin T., Coggeshall K.M. T Lymphocyte activation: A biological model of signal transduction. Crit. Rev. Immunol. 1990; 10: 347–391
   PubMed Web of Science ®Google Scholar
• Zerler B. The soluble interleukin-2 receptor as a marker for human neoplasia and immune status. Cancer Cells 1991; 3: 471–478
   PubMed Web of Science ®Google Scholar
• Ambrosetti A., Semenzato G., Prior M., Chilosi M., Vinante F., Vincenzi C., Zanotti R., Trentin L., Portuese A., Menestrina F., Perona G., Agostini C., Todeschini G., Pizzalo G. Serum levels of soluble interleukin-2 receptor in hairy cell leukemia: a reliable marker of neoplastic bulk. Br. J. Haematol. 1989; 73: 181–186
   PubMed Web of Science ®Google Scholar
• Barak V., Ginzburg M., Kalickman I., Polliack A. Serum soluble interleukin-2 receptor levels are associated with clinical disease status and histopathological grade in non-Hodgkin's lymphoma and chronic leukemia. Leukemia and Lymphoma 1992; 7: 431–438
   PubMed Web of Science ®Google Scholar
• Cimino G., Amadori S., Cava M.C., Sanctis V.D., Petti M.C., Gregorio A.O.D., Sgadari C., Vegna L., Cimino G., Mandelli F. Serum interleukin-2 (IL-2) soluble IL-2 receptors and tumor necrosis factor alfa levels are significantly increased in acute myeloid leukemia patients. Leukemia 1991; 5: 32–35
   PubMed Web of Science ®Google Scholar
• Gause A., Wolfram J., Keymis S., Schobert I., Scholz R., Schmits R., Diehl V., Pohl C., Hasenclever D., Pfreundschuh M. The clinical significance of cytokines and soluble forms of membrane derived activation antigens in the Serum of patients with Hodgkin's disease. leukemia and Lymphoma 1992; 7: 439–447
   PubMed Web of Science ®Google Scholar
• Matsuura T., West G.A., Klein J.S., Ferraris L., Fiocchi C. Soluble interleukin 2 and CD8 and CD4 receptors in inflammatory bowel disease. Gastroenterology 1992; 10: 2006–2014
   Google Scholar
• Musolino C., Cesare E.D., Alonci A., Allegra A., Orlando A., Grosso P., Squadrito G. Serum levels of CD8 antigen and soluble interleukin 2 receptors in patients with B cell chronic lymphocytic leukemia. Acta Haematol. 1991; 85: 57–61
   PubMed Web of Science ®Google Scholar
• Pui C.H., Schell M.J., Vodian M.A., Kline S., Mirro J., Crist W.M., Behm F.G. Serum CD4, CD8 and interleukin-2 receptor levels in childhood acute myeloid leukemia. Leukemia 1991; 5: 249–254
   PubMed Web of Science ®Google Scholar
• Santelises M.A., Lofentenius A., Ljungh C., Svenson S.B., Anderson B., Mellstedt H., Jondal M. Serum levels of helper factors (IL-1α, IL-1β and IL-6), T-cell products (sCD4 and sCD8), sIL-2R and β2-microglobulin in patients with B-CLL and benign B lymphocytosis. Leukemia Res. 1992; 16: 607–613
   PubMed Web of Science ®Google Scholar
• Yasuda N., Lai P.K., Ip S.H., Kung P.C., Hinuma Y., Matsuoka M., Hattori T., Takatsuki K., Purtillo D.T. Soluble interleukin-2 receptors in sera of Japanese patients with adult T-cell leukemia mark activity of disease. Blood 1988; 71: 1021–1026
   PubMed Web of Science ®Google Scholar
• Tomkinson B.E., Brown M.C., Ip S.H., Carrabis S., Sullivan J.L. Soluble CD8 during T-cell activation. J. Immunol. 1989; 142: 2230–2236
   PubMed Web of Science ®Google Scholar
• Pui C.H., Ip S.H., Dodge R.K., Carrabis S., Brown M., Crist W.M., Berard C.W., Kung P., Dahl G.V., Murphy S.B. Serum levels of CD8 antigen in childhood lymphoid malignancies: A possible indicator of increased suppressor cell activity in poor risk patients. Blood 1988; 72: 1015–1021
   PubMed Web of Science ®Google Scholar
• Pui C.H., Ip S.H., Thompson E., Dodge R.K., Brown M., Williams J., Carrabis S., Kung P., Berard C.W., Crist W.M. Increased CD8 antigen level in childhood Hodgkin's disease relates to advanced stage and poor treatment outcome. Blood 1989; 73: 209–213
   PubMed Web of Science ®Google Scholar
• Ho A.D., Grossman M., Trumper L., Pezzutto A., Pralle H., Radzun S.B., Papendick U., God B., Zwingers T., Hunstein W. Clinical implications of increased plasma levels of CD8 in patients with hairy cell leukemia. Blood 1990; 75: 1119–1124
   PubMed Web of Science ®Google Scholar
• Rothlein R., Mainolfi E.A., Czajkowski M., Marlin S.D. A form of circulating ICAM-1 in human serum. J. Immunol. 1991; 147: 3788–3792
   PubMed Web of Science ®Google Scholar
• Springer T.A. Adhesion receptors of the immune system. Nature 1990; 346: 425–434
   PubMed Web of Science ®Google Scholar
• Jewell A.P., Young K.L., Worman C.P., Giles F.J., Goldstone A.H., Lydyard P.M. Cytokine induction of leukocyte adhesion molecule-1 (LAM-1) expression on chronic lymphocytic leukemia cells. Leukemia 1992; 6: 400–404
   PubMed Web of Science ®Google Scholar
• Harning R., Mainolfi E., Bystryn J.C., Henn M., Merluzzi V.J., Rothlein R. Serum levels of circulating intercellular adhesion molecule 1 in human malignant melanoma. Cancer Res. 1991; 51: 5003–5005
   PubMed Web of Science ®Google Scholar
• Lai R.B., Mainolfi E., Rothstein R. Elevated levels of cICAM-1 in patients with human T-cell leukemia virus type 1 associated myelopathy and adult T-cell leukemia. Blood 1992; 80: 2434–2435
   PubMed Web of Science ®Google Scholar
• Shijubo N., Imai K., Aoki S., Hirasawa M., Sugawara H., Koba H., Tsujisaki M., Sugiyama T., Hinoda Y., Ya-Chi A., Asakawa M., Suzuki A. Circulating intercellular adhesion molecule-1 (ICAM-1) antigen in sera of patients with idiopathic pulmonary fibrosis. Clin. Exp. Immunol. 1992; 89: 58–62
   PubMed Web of Science ®Google Scholar
• Tsujisaki M., Imai K., Hirata H., Hanzawa Y., Masuya J., Nakano T., Sugiyama T., Matsui M., Hinoda Y., Yachi A. Detection of circulating intercellular adhesion molecule 1 antigen in malignant diseases. Clin. Exp. Immunol. 1991; 85: 3–8
   PubMed Web of Science ®Google Scholar
• Wegner C.D., Gundel R.H., Reilly P., Haynes N., Letts G., Rothlein R. Intercellular adhesion molecule-1 (ICAM-1) in the pathogenesis of asthma. Science 1990; 247: 456
   PubMed Web of Science ®Google Scholar
• Srivastava B.I.S., Wright J.J., Bakshi A. Immunoglobulin chain gene rearrangements in a t(4;ll) acute leukemia with monocytoid blasts. Br. J. Haematol. 1986; 63: 321–329
   PubMed Web of Science ®Google Scholar
• Maio M., Pinto A., Carbone A., Zagonel V., Gloghini A., Marotta G., Cirillo D., Colombatti A., Ferrara F., Vecchio L.D., Ferrone S. Differential expression of CD54/intercellular adhesion molecule-1 in myeloid leu-kemias and in lymphoproliferative disorders. Blood 1990; 76: 783–790
   PubMed Web of Science ®Google Scholar
• Kluin-Nelemans H.D. Hairy cell leukemia and its T Cell interactions. Leukemia and Lymphoma 1991; 4: 159–166
   PubMed Web of Science ®Google Scholar
• Pui C.H., Ip S.H., Iflah S., Behm F.G., Grose B.H., Dodge R.K., Crist W.M., Furman W.L., Murphy S.B., Rivera G. Serum interleukin-2 receptor levels in childhood lymphoblastic leukemia. Blood 1988; 71: 1135–1137
   PubMed Web of Science ®Google Scholar
• Srivastava B.I.S., Srivastava A., Srivastava M.D. Acute leukemia involving progenitors of Dendritic Langerhans cells (DLCs)—A new entity. Proc. Amer. Assoc. Cancer Res. 1991; 32: 169
   Google Scholar
• Srivastava B.I.S., Chervinsky D.S., Grossi M., Brecher M.L. A pediatric patient with acute leukemia involving progenitors of Dendritic Langerhans cells (DLCs). Proc. Amer. Assoc. Cancer Res. 1992; 33: 203
   Google Scholar
• Archimbaud E., Thomas X., Campos L., Magaud J.P., Dore J.F., Fiere D. Expression of adhesion molecules CD54 (ICAM-1) and CD58 (LFA-3) in adult acute leukemia: Relationship with initial characteristics and prognosis. Leukemia 1992; 6: 265–271
   PubMed Web of Science ®Google Scholar
• Sahraoui Y., Allouche M., Ammar A., Spanakis E., Clemenceau C., Jasmin C., Perraki M., Mollot C.V., Georgoulias V. Interleukin 2 production and interleu-kin 2 receptor expression by human immature leukemic T cells. Leukemia 1992; 6: 1025–1035
   PubMed Web of Science ®Google Scholar
• Fukudome K., Furose M., Fukuhara N., Orvita S., Imai T., Takagi S., Nagira M. Strong induction of ICAM-1 in human T-cells transformed by human T-cell leukemia virus type 1 and depression of ICAM-1 or LFA-1 in adult T-cell leukemia derived cell lines. Int. J. Cancer 1992; 52: 418–427
   PubMed Web of Science ®Google Scholar
• Armitage R.J., Lai A.P., Roberts P.J., Cawley J.C. Certain myeloid cells possess receptors for inter-leukin-2. Br. J. Haematol. 1986; 64: 799–807
   PubMed Web of Science ®Google Scholar